Literature DB >> 9927617

Replacement of threonine 394 by alanine facilitates internalization and resensitization of the rat mu opioid receptor.

R Wolf1, T Koch, S Schulz, M Klutzny, H Schröder, E Raulf, F Bühling, V Höllt.   

Abstract

Signaling of G protein-coupled receptors is terminated by phosphorylation of intracellular serine and threonine residues. Resensitization of these receptors requires internalization and subsequent dephosphorylation. We have recently shown that the resensitization rate of the rat micro opioid receptor (MOR) isoforms MOR1 and MOR1B is mainly determined by the amino acid composition of their alternatively spliced C-terminal tails. Upon agonist stimulation, MOR1B passes through an accelerated cycle of receptor endocytosis and reactivation, which in turn promotes a greater resistance to agonist-induced desensitization, as compared with MOR1. Given the fact that MOR1B lacks only one putative phosphorylation site (T394 of MOR1), we replaced this threonine by an alanine and stably expressed the wild-type MOR1 and its T394A mutant in mouse neuroblastoma Neuro2a cells. We show that during prolonged [D-Ala2, MePhe4, Gly5-ol]enkephalin exposure (5 h), the T394A receptor mutant desensitized at a slower rate than MOR1. In contrast, T394A is more rapidly removed from the cell surface than MOR1, as determined by flow cytometry using epitope-tagged receptors. This fast internalization was followed by immediate resensitization of T394A during 20 min of agonist removal while the wild-type MOR1 remained inactive. Similar to MOR1B, rapid internalization and reactivation of T394A may explain its delayed desensitization. These findings suggest that T394 represents a negative regulatory signal for MOR1 internalization. Furthermore, phosphorylation of this threonine residue may influence the time course of micro opioid receptor resensitization.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9927617     DOI: 10.1124/mol.55.2.263

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  16 in total

1.  Chronic morphine treatment reduces recovery from opioid desensitization.

Authors:  Vu C Dang; John T Williams
Journal:  J Neurosci       Date:  2004-09-01       Impact factor: 6.167

2.  Protein kinase C-mediated phosphorylation of the μ-opioid receptor and its effects on receptor signaling.

Authors:  Bo Feng; Zhihua Li; Jia Bei Wang
Journal:  Mol Pharmacol       Date:  2011-01-06       Impact factor: 4.436

Review 3.  Functional selectivity at the μ-opioid receptor: implications for understanding opioid analgesia and tolerance.

Authors:  Kirsten M Raehal; Cullen L Schmid; Chad E Groer; Laura M Bohn
Journal:  Pharmacol Rev       Date:  2011-08-26       Impact factor: 25.468

4.  Agonist Binding and Desensitization of the μ-Opioid Receptor Is Modulated by Phosphorylation of the C-Terminal Tail Domain.

Authors:  William T Birdsong; Seksiri Arttamangkul; James R Bunzow; John T Williams
Journal:  Mol Pharmacol       Date:  2015-05-01       Impact factor: 4.436

5.  Alternatively spliced mu opioid receptor C termini impact the diverse actions of morphine.

Authors:  Jin Xu; Zhigang Lu; Ankita Narayan; Valerie P Le Rouzic; Mingming Xu; Amanda Hunkele; Taylor G Brown; William F Hoefer; Grace C Rossi; Richard C Rice; Arlene Martínez-Rivera; Anjali M Rajadhyaksha; Luca Cartegni; Daniel L Bassoni; Gavril W Pasternak; Ying-Xian Pan
Journal:  J Clin Invest       Date:  2017-03-20       Impact factor: 14.808

6.  Agonist-selective patterns of µ-opioid receptor phosphorylation revealed by phosphosite-specific antibodies.

Authors:  Christian Doll; Jens Konietzko; Florian Pöll; Thomas Koch; Volker Höllt; Stefan Schulz
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

7.  T394A Mutation at the μ Opioid Receptor Blocks Opioid Tolerance and Increases Vulnerability to Heroin Self-Administration in Mice.

Authors:  Xiao-Fei Wang; Elisabeth Barbier; Yi-Ting Chiu; Yi He; Jia Zhan; Guo-Hua Bi; Hai-Ying Zhang; Bo Feng; Lee-Yuan Liu-Chen; Jia Bei Wang; Zheng-Xiong Xi
Journal:  J Neurosci       Date:  2016-10-05       Impact factor: 6.167

8.  Pharmacokinetic-pharmacodynamic analysis of the EEG effect of alfentanil in rats following beta-funaltrexamine-induced mu-opioid receptor "knockdown" in vivo.

Authors:  M Garrido; J Gubbens-Stibbe; E Tukker; E Cox; J von Frijtag; D Künzel; A IJzerman; M Danhof; P H van der Graaf
Journal:  Pharm Res       Date:  2000-06       Impact factor: 4.200

Review 9.  Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance.

Authors:  John T Williams; Susan L Ingram; Graeme Henderson; Charles Chavkin; Mark von Zastrow; Stefan Schulz; Thomas Koch; Christopher J Evans; Macdonald J Christie
Journal:  Pharmacol Rev       Date:  2013-01-15       Impact factor: 25.468

10.  Identification of five mouse mu-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon.

Authors:  Glenn A Doyle; X Rebecca Sheng; Sharon S J Lin; Danielle M Press; Dorothy E Grice; Russell J Buono; Thomas N Ferraro; Wade H Berrettini
Journal:  Gene       Date:  2007-02-20       Impact factor: 3.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.